Hims & Hers Logs Strong Q1 2026 Results, Poised for Future Growth
May 11, 2026 - Hims & Hers Health reported strong first quarter results today, highlighting key areas of progress that underscore its confidence in achieving ambitious 2030 targets. The company's quarterly earnings call provided insight into the strategic objectives that will define its platform for the next decade.
The U.S. business is poised to accelerate as Hims & Hers introduces new specialties and shifts its weight loss strategy toward a globally unified approach. This marks a significant step forward in the company's efforts to expand its market reach and strengthen its competitive advantage. By expanding its scale, Hims & Hers has not only increased its total addressable market (TAM) but also enhanced its value proposition for industry partners and strengthened network effects within its platform.
CEO Andrew Dudum highlighted several key areas of progress during the call. Firstly, the company is deepening customer relationships while filling real gaps in traditional care systems with a more proactive care offering. This creates opportunities for longer-term relationships with customers and positions Hims & Hers as an everyday health partner, not just for its current 2.6 million-strong user base but also for millions more around the world.
Dudum emphasized that continued investment in data and technology infrastructure is building an increasingly agile platform that gets smarter with every new customer interaction. This closed-loop provider network enables faster geographic and product expansion, more valuable customer interactions, and deeper platform engagement. Hims & Hers' robust data set is difficult to replicate, giving the company a significant advantage in its quest for future growth.
In the U.S., the breadth of care that Hims & Hers can provide has become a real strategic advantage, offering customers multiple entry points into the platform and compelling reasons to stay with the company over time. Momentum is building in newer specialties like testosterone, menopause, and labs, as well as accelerating growth in weight loss business thanks to expanding branded GLP-1 solutions.
Hims & Hers' strong start to 2026 reinforces confidence in its ambitious 2030 targets. With a solid foundation in place, the company is primed for future success, poised to become an everyday health partner for millions more around the world.
